Clik here to view.
Samsung Bioepis First to Obtain European Commission Approval for a Third...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Imraldi®, a biosimilar referencing Humira® 1 (adalimumab), for the treatment of rheumatoid...
View ArticleClik here to view.
Kyowa Hakko Kirin Co., Ltd.: US Food and Drug Administration Grants...
TOKYO Kyowa Hakko Kirin Co., Ltd. (TOKYO:4151)(President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) today announced that U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
View ArticleClik here to view.
GN Hearing宣布为近日推出的ReSound LiNX 3D供应充电解决方案
丹麦哥本哈根 (美国商业资讯)–GN Hearing面向革命性的ReSound LiNX 3D助听器推出充电电池方案。这款充电电池解决方案赋予ReSound用户更多的方案选择，将于9月1日起在北美及其他主要市场供应。在北美地区，该充电方案还适用于Beltone Trust，并将从9月1日起向其他主要市场扩展。 Smart News...
View ArticleClik here to view.
GRAMINEX L.L.C.在韩国首尔开张新办事处Graminex Korea Co., Ltd.
密歇根州萨基诺 (美国商业资讯)–Graminex® Flower Pollen Extracts™的生产商Graminex® LLC欣然宣布，Graminex® Korea Co., Ltd.开张。Sun-Ho Frank Kim博士被任命为韩国首尔当地办事处的董事总经理。 Sun-Ho Frank...
View ArticleClik here to view.
グラミネックス、韓国ソウルに新事務所「グラミネックス・コリア」を開設
米ミシガン州サギノー （ビジネスワイヤ）– グラミネックス花粉エキスを生産するグラミネックス（Graminex® LLC）は、グラミネックス・コリアの開設を発表します。キム・スンホ・フランク博士（Ph.D.）が韓国ソウルの現地事務所のマネジングディレクターに任命されました。...
View ArticleClik here to view.
MOLOGEN AG and Chinese iPharma Ltd. signed binding term sheet for a...
BERLIN The biopharmaceutical company MOLOGEN AG (ISIN DE0006637200; Frankfurt Stock Exchange Prime Standard: MGN) announced today the signing of a binding term sheet that defines the framework for...
View ArticleClik here to view.
Study Evaluates Utility of Masimo SpHb® During High-Blood-Loss Oncosurgery
NEUCHATEL, Switzerland Masimo (NASDAQ:MASI) announced today the findings of a recently published study in which researchers in New Delhi, India evaluated the utility of Masimo SpHb®, noninvasive,...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Cefixime for Oral...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Cefixime for Oral Suspension, USP 100 mg/5mL and 200...
View ArticleClik here to view.
Nihon Kohden Launches Global Education and Training Platform
IRVINE, Calif. Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the launch of Nihon Kohden University, a global education and training platform designed...
View ArticleClik here to view.
研究评估Masimo SpHb®在高失血量肿瘤手术中的功用
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ:MASI)今天发布了印度新德里研究人员最新发表的一项研究结果，该研究评估Masimo无创连续血红蛋白测量指标SpHb®在预期高失血量的肿瘤手术患者中的功用1。...
View ArticleClik here to view.
失血量が多い腫瘍手術中における研究でMasimo SpHb®の有用性を評価
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、インドのニューデリーの研究者らが最近発表した研究の知見について発表しました。この研究は、大量の失血が予想される患者を対象に、非侵襲的かつ連続的なヘモグロビン測定値であるMasimo SpHb®の腫瘍手術中における有用性を評価したものです1。...
View ArticleClik here to view.
Avita Medical Names Erin Liberto as Chief Commercial Officer
VALENCIA, Calif. & PERTH, Australia & LONDON Avita Medical, Ltd. (ASX: AVH), (OTCQX: AVMXY), a medical device company developing innovative therapeutic solutions derived from the...
View ArticleClik here to view.
Leading Immunologists Gather in New Delhi to Confront Celiac Disease
CAMBRIDGE, Mass. & NEW DELHI The International Society for the Study of Celiac Disease (ISSCD), a non-profit organization of professionals working in the field of celiac disease and...
View ArticleClik here to view.
BioMarker Strategies Announces Two New Patents Granted in Japan, Covering the...
ROCKVILLE, Md. BioMarker Strategies, LLC, today announced that the Japan Patent Office has granted new patents covering the Company’s SnapPath® Cancer Diagnostics System technology and its PathMAP®...
View ArticleClik here to view.
Sosei: First Subject Dosed in Phase1 Clinical Study of Novel Selective...
TOKYO Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) today reported that Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei, announces that the first healthy...
View ArticleClik here to view.
Yamaha Motor Releases the Cell Picking & Imaging System CELL HANDLER(TM)
IWATA, Japan Yamaha Motor Co., Ltd. (TOKYO:7272) (ISIN:JP3942800008) announced today that it has developed the cell picking/imaging system CELL HANDLERTM. This device performs part of the testing...
View ArticleClik here to view.
Taro Announces Joining of CEO
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that Mr. Uday Baldota has joined the Company as its Chief Executive Officer (“CEO”)...
View ArticleClik here to view.
Therapure Biopharma Inc. Announces Spin Off and Sale of Contract Development...
MISSISSAUGA, Ontario Therapure Biopharma Inc. (“Therapure” or the “Company”) today announced that a joint venture between 3SBio Inc. (HKG:1530) (“3SBio”), a leading global biotechnology company, and...
View ArticleClik here to view.
1st Patient Recruited in Orthocell Ortho-ATI® Shoulder Tendon Study
PERTH, Australia Regenerative medicine company Orthocell Limited (ASX:OCC) today announced that it has recruited and treated its first patient in a randomised, controlled clinical trial of...
View ArticleClik here to view.
Co-Diagnostics, Inc. to Sign Purchase Agreement with MEDCIS Pathlabs
SANDY, Utah Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, and...
View Article